Drugs / Restalyne Silk
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02818556 | Jun 2016 → Jan 2017 | follicular atrophoderma, perioral pigmented, with milia and epidermoid cysts | The Maas Clinic | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Restalyne Silk | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02818556 ↗ |
| Known as | Restylane Silk | “Fifty patients will receive one treatment session consisting of Restylane® Silk (right side of the face) and Belotero Balance® (left side), or vice versa (1:1 dose conversion...” NCT02818556 ↗ |